(FM) Neurología

2024

1. Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis

   Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574

2. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression

   Journal of Clinical Immunology, Vol. 44, Núm. 6

3. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report

   Journal of Neurology

4. Checkmate: Chess-induced reflex seizures in patient with juvenile myoclonic epilepsy

   Epileptic Disorders, Vol. 26, Núm. 1, pp. 144-147

5. Clusters of cognitive performance predict long-term cognitive impairment in elderly patients with subjective memory complaints and healthy controls

   Alzheimer's and Dementia, Vol. 20, Núm. 7, pp. 4702-4716

6. Dendritic Cells in Cancer Immunology and Immunotherapy

   Cancers, Vol. 16, Núm. 5

7. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

   Neurologia

8. Efficacy and tolerability of add-on stiripentol in real-world clinical practice: An observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies

   Epilepsia Open, Vol. 9, Núm. 1, pp. 164-175

9. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

   Frontiers in Neurology , Vol. 15

10. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol

    Journal of Headache and Pain, Vol. 25, Núm. 1

11. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

    European Journal of Neurology, Vol. 31, Núm. 6

12. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

13. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

    The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216

14. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Journal of Headache and Pain, Vol. 25, Núm. 1

15. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

16. Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)-Thalamotomy for Essential Tremor: Lesion Location and Clinical Outcomes

    Movement Disorders, Vol. 39, Núm. 6, pp. 1015-1025

17. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus

    Movement Disorders, Vol. 39, Núm. 2, pp. 235-248

18. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment

    Medicina Clinica, Vol. 163, Núm. 4, pp. 208.e1-208.e10

19. Neuropsychological differences in Alzheimer's disease depending on the age of onset

    Revista Espanola de Geriatria y Gerontologia, Vol. 59, Núm. 1

20. Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes

    Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57